Hepatocellular Carcinoma
Researchers' work from Austria, Singapore and the People's Republic of China adds to hepatocellular carcinoma body of knowledge
Published in Gene Therapy Weekly, October 12th, 2006
Study 1: Hepatocellular carcinoma (HCC) could be linked to the epigenetic silencing of NORE1B, a candidate tumor suppressor.
"In HCC the ras-proto-oncogene is rarely mutated. We therefore studied the possible inactivation of the putative tumor-suppressors and ras-associating proteins, NORE1A, NORE1B, and RASSF1A in HCCs by mutation or epigenetic gene silencing through promoter-CpG hypermethylation. SSCP-analyses, sequencing, and methylation-specific PCR were performed in 28 fibrotic/cirrhotic livers and 40 HCCs," investigators in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-10-12)
More Articles from Gene Therapy Weekly
- Antisense Technology
Neurodegenerative disease therapy can utilize antisense oligonucleotides - Colitis
Colitis therapeutic target identified - Gene Silencing
Myostatin silenced in embryonic myoblast differentiation - Neuroscience
Heterotopia formation occurs in rat neocortex after RNA interference knockdown - Stem Cell Research
Embryonic stem cell reversible gene expression induced by a RNA vector - Adverse Drug Reaction
Cardiotoxicity of the cancer therapeutic agent imatinib mesylate documented - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
